Home » Authors » Mark McCarty

Articles by Mark McCarty

International Technidyne gets multiple-citation warning letter

Dec. 21, 2007

By Mark McCarty

Senate bill seeks to block 10% Part B cuts, offers CHIP fix

Dec. 20, 2007

By Mark McCarty

FDA's off-label promo guidance draws flack from Rep. Waxman

Dec. 18, 2007

By Mark McCarty

Hologic gets panel approval for Adiana contraceptive device

Dec. 17, 2007

By Mark McCarty

At issue: Can state courts rule FDA-approved devices defective

Dec. 5, 2007

By Mark McCarty

HeartMate II gets panel approval despite excess bleeding data

Dec. 4, 2007

By Mark McCarty

Xience, 2nd 2.0 DES, gets panel OK, also thumbs-up for HMII

Dec. 1, 2007

By Mark McCarty

HHS pitches hospital payment reform proposal to Congress

Nov. 29, 2007

By Mark McCarty

Panel: specialty society 'sway' on reimbursement is growing

Nov. 21, 2007

By Mark McCarty

Maker of screws falls short on validation, device documents

Nov. 21, 2007

By Mark McCarty

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...